Literature DB >> 24025159

Influence of biphasic β-TCP with and without the use of collagen membranes on bone healing of surgically critical size defects. A radiological, histological, and histomorphometric study.

Jose L Calvo-Guirado1, Maria P Ramírez-Fernández1, Rafael A Delgado-Ruíz2, Jose E Maté-Sánchez1, Pablo Velasquez3, Piedad N de Aza3.   

Abstract

OBJECTIVES: The aim of this study was to investigate, by means of radiological and histomorphometric analysis, the effect of resorbable collagen membranes on critical size defects (CSD) in rabbit tibiae filled with biphasic calcium phosphate.
MATERIALS AND METHODS: Three CSD of 6 mm diameter were created in both tibiae of 20 New Zealand rabbits and divided into three groups according to the filling material: Group A (Ossceram), Group B (Ossceram plus Alveoprotect membrane), and Group C (unfilled control group). Five animals from each group were sacrificed after 15, 30, 45, and 60 days. Anteroposterior and lateral radiographs were taken. Samples were processed for observation under light microscopy.
RESULTS: At the end of treatment, radiological analysis found that cortical defect closure was greater in Group B than Group A, and radiopacity was clearly lower and more heterogeneous in the Group A cortical defects than in Group B. There was no cortical defect closure in Group C. Histomorphometric evaluation showed significant differences in newly formed bone and cortical closure in Group B compared with Groups A and C, with the presence of higher density newly formed bone in cortical and medullar zones. There was no cortical defect closure or medullar bone formation in Group C.
CONCLUSIONS: Biphasic calcium phosphate functioned well as a scaffolding material allowing mineralized tissue formation. Furthermore, the addiction of absorbable collagen membranes enhanced bone gain compared with non-membrane-treated sites.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bone substitute; collagen membrane; critical size defects; guide bone regeneration; hydroxyapatite; tricalcium phosphate

Mesh:

Substances:

Year:  2013        PMID: 24025159     DOI: 10.1111/clr.12258

Source DB:  PubMed          Journal:  Clin Oral Implants Res        ISSN: 0905-7161            Impact factor:   5.977


  6 in total

1.  The Influences of Different Ratios of Biphasic Calcium Phosphate and Collagen Augmentation on Posterior Lumbar Spinal Fusion in Rat Model.

Authors:  Kyung Hyun Kim; Jeong Yoon Park; Hyo Suk Park; Keun Su Kim; Dong Kyu Chin; Yong Eun Cho; Sung Uk Kuh
Journal:  Yonsei Med J       Date:  2017-03       Impact factor: 2.759

2.  Morphological and Structural Study of a Novel Porous Nurse's A Ceramic with Osteoconductive Properties for Tissue Engineering.

Authors:  Ruben Rabadan-Ros; Pablo A Velásquez; Luis Meseguer-Olmo; Piedad N De Aza
Journal:  Materials (Basel)       Date:  2016-06-15       Impact factor: 3.623

3.  SEM-EDX Study of the Degradation Process of Two Xenograft Materials Used in Sinus Lift Procedures.

Authors:  María Piedad Ramírez Fernández; Sergio A Gehrke; Carlos Pérez Albacete Martinez; Jose L Calvo Guirado; Piedad N de Aza
Journal:  Materials (Basel)       Date:  2017-05-17       Impact factor: 3.623

Review 4.  Bone regenerative medicine: classic options, novel strategies, and future directions.

Authors:  Ahmad Oryan; Soodeh Alidadi; Ali Moshiri; Nicola Maffulli
Journal:  J Orthop Surg Res       Date:  2014-03-17       Impact factor: 2.359

5.  Bone regeneration using a porcine bone substitute collagen composite in vitro and in vivo.

Authors:  Eisner Salamanca; Chia-Chen Hsu; Haw-Ming Huang; Nai-Chia Teng; Che-Tong Lin; Yu-Hwa Pan; Wei-Jen Chang
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

6.  Demineralized Bone Matrix Coating Si-Ca-P Ceramic Does Not Improve the Osseointegration of the Scaffold.

Authors:  Andrés Parrilla-Almansa; Nuria García-Carrillo; Patricia Ros-Tárraga; Carlos M Martínez; Francisco Martínez-Martínez; Luis Meseguer-Olmo; Piedad N De Aza
Journal:  Materials (Basel)       Date:  2018-09-01       Impact factor: 3.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.